Request Demo
Last update 08 May 2025
Rosuvastatin Calcium/Nebivolol Hydrochloride
Last update 08 May 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Nebivolol/rosuvastatin, Rosuvastatin/nebivolol |
Action inhibitors, antagonists |
Mechanism HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors), β1-adrenergic receptor antagonists(Beta-1 adrenergic receptor antagonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (30 Aug 2019), |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC22H28CaFN3O6S |
InChIKeyAVDMILNVMOXCHF-DHMAKVBVSA-N |
CAS Registry147098-20-2 |
Related
1
Clinical Trials associated with Rosuvastatin Calcium/Nebivolol HydrochlorideKCT0002283
A randomized, open-label, single dose, 2-way crossover study to evaluate the pharmacokinetic characteristics of EL-1401 in comparison to the co-administration of nebivolol and rosuvastatin in healthy volunteers
100 Clinical Results associated with Rosuvastatin Calcium/Nebivolol Hydrochloride
Login to view more data
100 Translational Medicine associated with Rosuvastatin Calcium/Nebivolol Hydrochloride
Login to view more data
100 Patents (Medical) associated with Rosuvastatin Calcium/Nebivolol Hydrochloride
Login to view more data
100 Deals associated with Rosuvastatin Calcium/Nebivolol Hydrochloride
Login to view more data
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Chronic heart failure | South Korea | 30 Aug 2019 | |
| Essential Hypertension | South Korea | 30 Aug 2019 | |
| Homozygous familial hypercholesterolemia | South Korea | 30 Aug 2019 | |
| Primary hypercholesterolemia | South Korea | 30 Aug 2019 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free